BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32819584)

  • 1. A novel ADPKD model using kidney organoids derived from disease-specific human iPSCs.
    Shimizu T; Mae SI; Araoka T; Okita K; Hotta A; Yamagata K; Osafune K
    Biochem Biophys Res Commun; 2020 Sep; 529(4):1186-1194. PubMed ID: 32819584
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Kuraoka S; Tanigawa S; Taguchi A; Hotta A; Nakazato H; Osafune K; Kobayashi A; Nishinakamura R
    J Am Soc Nephrol; 2020 Oct; 31(10):2355-2371. PubMed ID: 32747355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystic renal-epithelial derived induced pluripotent stem cells from polycystic kidney disease patients.
    Kenter AT; Rentmeester E; van Riet J; Boers R; Boers J; Ghazvini M; Xavier VJ; van Leenders GJLH; Verhagen PCMS; van Til ME; Eussen B; Losekoot M; de Klein A; Peters DJM; van IJcken WFJ; van de Werken HJG; Zietse R; Hoorn EJ; Jansen G; Gribnau JH
    Stem Cells Transl Med; 2020 Apr; 9(4):478-490. PubMed ID: 32163234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human iPSC-derived renal collecting duct organoid model cystogenesis in ADPKD.
    Mae SI; Hattanda F; Morita H; Nozaki A; Katagiri N; Ogawa H; Teranaka K; Nishimura Y; Kudoh A; Yamanaka S; Matsuse K; Ryosaka M; Watanabe A; Soga T; Nishio S; Osafune K
    Cell Rep; 2023 Dec; 42(12):113431. PubMed ID: 38039961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of special autosomal dominant polycystic kidney disease iPSCs with the capability of functional kidney-like cell differentiation.
    Huang J; Zhou S; Niu X; Hu B; Li Q; Zhang F; Zhang X; Cai X; Lou Y; Liu F; Xu C; Wang Y
    Stem Cell Res Ther; 2017 Sep; 8(1):196. PubMed ID: 28927462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney organoids generated from erythroid progenitors cells of patients with autosomal dominant polycystic kidney disease.
    Facioli R; Lojudice FH; Anauate AC; Maquigussa E; Nishiura JL; Heilberg IP; Sogayar MC; Boim MA
    PLoS One; 2021; 16(8):e0252156. PubMed ID: 34339420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid target validation in a Cas9-inducible hiPSC derived kidney model.
    Shamshirgaran Y; Jonebring A; Svensson A; Leefa I; Bohlooly-Y M; Firth M; Woollard KJ; Hofherr A; Rogers IM; Hicks R
    Sci Rep; 2021 Aug; 11(1):16532. PubMed ID: 34400685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cardiac manifestation of autosomal dominant polycystic kidney disease revealed by patient induced pluripotent stem cell-derived cardiomyocytes.
    Lee JJ; Cheng SJ; Huang CY; Chen CY; Feng L; Hwang DY; Kamp TJ; Chen HC; Hsieh PCH
    EBioMedicine; 2019 Feb; 40():675-684. PubMed ID: 30639418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three-dimensional in vitro models answer the right questions in ADPKD cystogenesis.
    Dixon EE; Woodward OM
    Am J Physiol Renal Physiol; 2018 Aug; 315(2):F332-F335. PubMed ID: 29693448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis in patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD): Identification of five mutations in the PKD1 gene.
    Abdelwahed M; Hilbert P; Ahmed A; Mahfoudh H; Bouomrani S; Dey M; Hachicha J; Kamoun H; Keskes-Ammar L; Belguith N
    Gene; 2018 Sep; 671():28-35. PubMed ID: 29860066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult human kidney organoids originate from CD24
    Xu Y; Kuppe C; Perales-Patón J; Hayat S; Kranz J; Abdallah AT; Nagai J; Li Z; Peisker F; Saritas T; Halder M; Menzel S; Hoeft K; Kenter A; Kim H; van Roeyen CRC; Lehrke M; Moellmann J; Speer T; Buhl EM; Hoogenboezem R; Boor P; Jansen J; Knopp C; Kurth I; Smeets B; Bindels E; Reinders MEJ; Baan C; Gribnau J; Hoorn EJ; Steffens J; Huber TB; Costa I; Floege J; Schneider RK; Saez-Rodriguez J; Freedman BS; Kramann R
    Nat Genet; 2022 Nov; 54(11):1690-1701. PubMed ID: 36303074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bilineal inheritance of pathogenic PKD1 and PKD2 variants in a Czech family with autosomal dominant polycystic kidney disease - a case report.
    Elisakova V; Merta M; Reiterova J; Baxova A; Kotlas J; Hirschfeldova K; Obeidova L; Tesar V; Stekrova J
    BMC Nephrol; 2018 Jul; 19(1):163. PubMed ID: 29973168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease.
    Ishimoto Y; Inagi R; Yoshihara D; Kugita M; Nagao S; Shimizu A; Takeda N; Wake M; Honda K; Zhou J; Nangaku M
    Mol Cell Biol; 2017 Dec; 37(24):. PubMed ID: 28993480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease (ADPKD).
    Hoefele J; Mayer K; Scholz M; Klein HG
    Nephrol Dial Transplant; 2011 Jul; 26(7):2181-8. PubMed ID: 21115670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monkeys mutant for PKD1 recapitulate human autosomal dominant polycystic kidney disease.
    Tsukiyama T; Kobayashi K; Nakaya M; Iwatani C; Seita Y; Tsuchiya H; Matsushita J; Kitajima K; Kawamoto I; Nakagawa T; Fukuda K; Iwakiri T; Izumi H; Itagaki I; Kume S; Maegawa H; Nishinakamura R; Nishio S; Nakamura S; Kawauchi A; Ema M
    Nat Commun; 2019 Dec; 10(1):5517. PubMed ID: 31822676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A loss-of-function model for cystogenesis in human autosomal dominant polycystic kidney disease type 2.
    Torra R; Badenas C; San Millán JL; Pérez-Oller L; Estivill X; Darnell A
    Am J Hum Genet; 1999 Aug; 65(2):345-52. PubMed ID: 10417277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-Scale Single Nucleotide Resolution Analysis of DNA Methylation in Human Autosomal Dominant Polycystic Kidney Disease.
    Bowden SA; Rodger EJ; Bates M; Chatterjee A; Eccles MR; Stayner C
    Am J Nephrol; 2018; 48(6):415-424. PubMed ID: 30463078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of human induced pluripotent stem cell line (MUi026-A) from a patient with autosomal dominant polycystic kidney disease carrying PKD1 point mutation.
    Maneepitasut W; Wongkummool W; Tong-Ngam P; Promthep K; Tubsuwan A; Khine Linn A; Phakdeekitcharoen B; Borwornpinyo S; Kitiyanant N; Phanthong P; Hongeng S
    Stem Cell Res; 2021 May; 53():102306. PubMed ID: 33799277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic Cysts in Autosomal Dominant Polycystic Kidney Disease: Prevalence and Association with PKD2 Gene Mutations.
    Kim JA; Blumenfeld JD; Chhabra S; Dutruel SP; Thimmappa ND; Bobb WO; Donahue S; Rennert HE; Tan AY; Giambrone AE; Prince MR
    Radiology; 2016 Sep; 280(3):762-70. PubMed ID: 27046073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced pluripotent stem cells derived from an autosomal dominant polycystic kidney disease patient carrying a PKD1 Q533X mutation.
    Lee JJ; Ho MC; Huang CY; Wen CH; Cheng YC; Hsu YH; Hwang DY; Lu HE; Chen HC; Hsieh PCH
    Stem Cell Res; 2017 Dec; 25():83-87. PubMed ID: 29121521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.